Pharmaceuticals — Editors

Journal Contact

Pharmaceuticals Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Dr. Jean Jacques Vanden Eynde
Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium
Interests: heterocycles; microwave-induced synthesis; medicinal chemistry; green chemistry
Prof. Dr. Shin Mineishi
Associate Editor
Director, Bone Marrow Transplantation and Cell Therapy Program, Division of Hematology & Oncology, The University of Alabama at Birmingham, 1802 6th Avenue South, NP 2562, Birmingham, AL 35294-3300, USA
Interests: bone marrow transplantation; graft versus host disease; complications after stem cell transplantation; reduced intensity stem cell transplantation; HLA-mismatch stem cell transplantation; graft engineering; cell therapy; and gene therapy
Dr. Annie Mayence
Associate Editor
Formerly professor at the Haute Ecole Provinciale de Hainaut-Condorcet, 7330 Saint-Ghislain, Belgium
Dr. Derek J. McPhee *
Former Editor-in-Chief
Director of Chemistry, Amyris, Inc., 5885 Hollis St, Suite 100, Emeryville, CA 94608, USA
Interests: organic synthesis; medicinal chemistry; biotechnology
* Founding Editor-in-Chief and Editor-in-Chief up to 29 January 2015.

Prof. Dr. Peter J. Barnes
National Heart and Lung Institute, Imperial College, London, UK
Interests: molecular mechanisms and therapy of asthma and COPD
Contribution: Special Issue: Antiasthmatic Drugs
Prof. Jean-Pierre Bazureau
University of Rennes 1, Institute of Chemical Sciences Rennes ICSR UMR CNRS 6226, Building 10A, Room 207, Campus de Beaulieu, 263 Avenue du General Leclerc, CS 74205, 35042 RENNES Cedex, France
Interests: synthetic organic chemistry under microwave; medicinal chemistry; design and heterocyclic chemistry for cancer and CNS diseases
Prof. Dr. Paul Cos
Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Antwerp University, campus drie eiken, building S, office 7.26 Universiteitsplein 1, B-2610 Antwerp, Belgium
Interests: anti-infective agents; biofilm; bacterial virulence; oxidative stress; antibacterial; antifungal; antiparasitic and antiviral
Contribution: Special Issue: Anti-Infective Agents
In other journals:
Special Issue: Anti-Infective Agents
Dr. Maria Emília de Sousa
Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências, Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira 228, 4050-313, Porto, Portugal; Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR/CIMAR), Universidade do Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal
Interests: medicinal chemistry; organic synthesis; heterocycles, P-glycoprotein; anticancer; anticoagulants; chiral drugs
Contribution: Special Issue: Grand Celebration: 100th Anniversary of the Discovery of Heparin
In other journals:
Special Issue: Selected Papers from the 6th International Conference on Natural Products for Health and Beauty (NATPRO 6)
Prof. Dr. Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg, 555128 Mainz, Germany
Interests: cancer; pharmacogenomics; molecular docking and virtual drug screening; molecular pharmacology; natural products; phytotherapy
Contribution: Special Issue: Phytomedicine
Dr. Arthur Gomtsyan
Abbvie Inc, Drug Discovery, 1 North Waukegan Road, Department ZR09, Bldg. AP10, North Chicago, IL 60064, USA
Interests: medicinal chemistry; synthetic organic chemistry; drug design in the area of pain and dermatology research
Contribution: Special Issue: Advances in Drug Design
Prof. Dr. Bernd Groner
Georg Speyer Haus, Institute for Tumor Biology and Experimental Therapy, Paul Ehrlich Str. 42, D-60596 Frankfurt am Main, Germany
Interests: cytokine signal transduction; peptide inhibitors of oncoproteins; breast cancer research; experimental tumor therapy
Contribution: Special Issue: Peptide Drug Discovery and Development
Dr. Rick Gussio
Section Chief, Computational Drug Development Group, Developmental Therapeutics Program, Division of Cancer Treatment & Diagnosis, National Cancer Institute, 8490 Progress Drive, Riverside 5, Suite 400, Room 4095, Frederick MD 21701, USA
Interests: structural medicinal chemistry; structure-based design & discovery; molecular modeling, bioinformatics; chemoinformatics; applied statistics; QSAR; computational chemistry; pharmacognosy
Prof. Dr. Michael Gütschow
Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53115 Bonn, Germany
Interests: synthetic organic chemistry; enzyme kinetics; mechanism-based enzyme inhibitors; inhibitors of proteases
Prof. Dr. Christian Hartinger
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Interests: development of metal-based drugs; mode of action studies; interaction with biomolecules and bioanalytical chemistry with a focus on mass spectrometric techniques coupled to separation methods
Prof. Dr. Tien L. Huang
Division of Basic and Pharmaceutical sciences, College of Pharmacy, Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA
Interests: medicinal chemistry; organic chemistry; anti-opportunistic agents; anti-parasitic agents; prodrugs
Dr. Kenneth A. Jacobson
Laboratory of Bioorganic Chemistry and Molecular Recognition Section, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bldg. 8A, Rm. B1A-19, 8 Center Dr., MSC-0810 Bethesda, MD 20892-0810, USA
Interests: medicinal chemistry; G protein-coupled receptors; receptor pharmacology; cell signaling; molecular modeling; purinergic receptors; adenosine receptors; chemistry of nucleosides and nucleotides; radiochemistry; nanotechnology and nanoscience
Dr. Svend Borup Jensen
Nuklearmedicinsk Afdeling - Hobrovej 18-22, Postboks 365, 9100 Aalborg, Denmark
Interests: PET-radiochemistry, gallium-68, drug degradation profiles; medicinal gum; infection imaging, analytical methods; medicinal chemistry
Contribution: Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development
In other journals:
Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development
Prof. Dr. Joachim Jose
PharmaCampus Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität, Corrensstr. 48, 48149, Muenster, Germany
Interests: autodisplay; assay development and inhibitor testing; whole cell biocatalysts for synthesis of drugs and building blocks; directed evolution of enzyme inhibitors and biocatalysts; biosensor development and diagnostic tools
Prof. Dr. Klaus Kopka
Division of Radiopharmaceutical Chemistry, Research Program Imaging and Radiooncology, German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Interests: radiopharmaceutical sciences; labeling chemistry; medicinal chemistry; PET tracers; radiopharmaceuticals for diagnostics and endoradiotherapy; small molecules; peptides; antibodies and derivatives thereof
Contribution: Special Issue: Radiopharmaceutical Chemistry between Imaging and Radioendotherapy
Prof. Dr. Christopher W.K. Lam
State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macau, China
Interests: allergy and clinical immunology; nephrology; diabetology; toxicology; clinical biochemistry; laboratory medicine; Chinese medicine
Contribution: In other journals:
Special Issue: Phytochemicals: Analytical and Medicinal Chemistry
Special Issue: Herbal Medicine Research
Prof. Dr. Peter A. Leggat
College of Public Health, Medical and Veterinary Sciences, Division of Tropical Health and Medicine, James Cook University, Townsville Qld 4811, Australia
Interests: occupational health and safety; injury prevention; pharmaceuticals; aerospace medicine; geographic and travel medicine
Contribution: Special Issue: Tropical Medicine
In other journals:
Special Issue: Occupational Health Issues in the New Millennium
Prof. Dr. Philip S. Low
Director of the Purdue Center for Drug Discovery, Ralph C. Corley Distinguished Professor, Department of Chemistry 720 Clinic Drive, Purdue University, West Lafayette, IN 47907, USA
Website: http:/
Interests: targeted Therapeutics; fluorescence-guided surgery; techniques for pathogen detection; human red blood cell membrane
Dr. Viktor P. Lozitsky
Research Center "Biomedical Testing of Preparations and Products", Odessa, Ukraine
Interests: proteolysis inhibitors; virus-cell interactions; antiviral compounds
Prof. Dr. Giuseppe Mancia
Clinical Medicine Unit, University of Milano-Bicocca, San Gerardo Hospital, Via Pergolesi, 33, 20052 Monza (MI), Italy
Interests: pathophysiology; clinical pharmacology and therapy of hypertension; congestive heart failure and other cardiovascular diseases
Contribution: Special Issue: Antihypertensive Drugs
Dr. Louis M. Mansky
Institute for Molecular Virology, University of Minnesota, 18-242 Moos Tower, 515 Delaware St. SE, Minneapolis, MN 55455, USA
Interests: antiretroviral; nucleoside; mutation; drug synergy; therapeutic indices
Contribution: Special Issue: Drug Repositioning
In other journals:
Special Issue: Recent Advances in HTLV Research 2015
Prof. Dr. Alberto M. Martelli
Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Cell Signalling Laboratory, School of Pharmacy, via Irnerio 48, 40126 Bologna BO, Italy
Interests: targeted therapies for acute leukemias; signal transduction pathways as innovative therapeutic targets; nuclear lipid-based signaling
Prof. Dr. Kevin H. Mayo
Department of Biochemistry, Molecular Biology & Biophysics, and the NCI-designated Comprehensive Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
Interests: protein and carbohydrate structure and function; NMR spectroscopy; structure-based drug design and discovery; angiogenesis; oncology; infectious disease
Prof. Dr. Jane McHowat
Department of Pathology, Saint Louis University School of Medicine, Schwitalla Hall, Room M207, 1402 S. Grand Blvd, St. Louis, MO 63104, USA
Interests: inflammation; phospholipases; breast cancer; interstitial cystitis; bladder; atherosclerosis; platelet-activating factor
Contribution: Topical Collection: Non-Steroidal Anti-Inflammatory Drugs
Prof. Dr. Paolo Montuschi
Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
Interests: asthma; chronic obstructive pulmonary disease (COPD); pharmacological therapy of asthma and COPD; allergy; non-invasive monitoring of lung inflammation; exhaled breath condensate; exhaled nitric oxide; electronic nose; metabolomics
Contribution: Special Issue: Antiasthmatic Drugs
Dr. Mark Murphy
Research Immunology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH- 4123 Allschwil, Switzerland
Interests: immunology; targeted therapies for inflammatory and autoimmune diseases; signal transduction pathways as innovative therapeutic targets; stem cells; protein-protein interactions; targeted therapies for cancer; cytokines/chemokines
Contribution: Special Issue: Chemokines
Dr. Mark H. Norman
Therapeutic Discovery Amgen Inc., One Amgen Center Drive, MS: B29 29-M-B Thousand Oaks, CA 91320-1799, USA
Interests: design and synthesis of new chemical entities (NCE) towards several targets mainly connected with cancer, pain and inflammation; lead discovery and optimization; medicinal chemistry
Dr. Emmanuel S. Onaivi
Department of Biology, William Paterson University, Wayne, NJ, 07470, USA
Interests: cannabinoids; endocannabinoid system; cannabinoid genetics and epigenetics; drug addiction; medical marijuana and cannabinoid pharmacogenomics
Contribution: Special Issue: Medical Marijuana
Prof. Dr. Ricardo E. Pérez-Tomás
Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, Campus de Bellvitge., Lab.5101 C./ Feixa Llarga s/n E- 08907, Hospitalet de Llobregat, Barcelona, Spain
Interests: new molecules for cancer chemotherapy; apoptosis; signal transduction for cancer chemotherapy
Prof. Dr. Yvonne Perrie
Aston Pharmacy School, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK
Interests: liposomes; gene therapy; vaccines; colloidal systems; pharmaceutics; pharmaceutical education; drug delivery
Contribution: In other journals:
Special Issue: What's on Board in Pharmaceutics
Special Issue: Gene Therapy
Special Issue: Feature Papers: Emerging Processes, Analytics and Dosage Forms in Pharmaceutical Processing and Drug Delivery
Dr. Suzanne Peyrottes
Institute for Biomolecules Max Mousseron (IBMM), UMR5247‐CNRS–UM–ENSCM, University Montpellier, cc1704, Place E. Bataillon, 34095 Montpellier, France
Interests: targeting of phosphorylated effectors; synergetic effect in antiviral chemotherapy; synthesis and study of phosphonate analogues as potential therapeutic agents; development of choline analogues as anti‐malarial agents
Prof. Dr. Leonidas A. Phylactou
Acting Chief Executive Medical Director, The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus
Interests: RNA biology; regulatory RNA molecules; muscle regeneration, identification of genetic defects in inherited diseases
Contribution: Special Issue: Gene Therapy
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
In other journals:
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
Prof. Dr. Maurizio Pompili
Department of Neurosciences, Mental Health and Sensory Organs. Director, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Italy
Interests: suicide and suicidal behavior; suicide prevention strategies
Prof. Dr. Thomas Rades
Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 København Ø, Denmark
Interests: the solid state of drugs and dosage forms; poorly water soluble drugs; amorphous drugs and drug delivery systems; lipid based drug delivery systems; analytical techniques in the solid state
Contribution: In other journals:
Special Issue: Poorly Soluble Drugs
Prof. Dr. Maurizio Recanatini
Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy
Interests: computational medicinal chemistry; structure-based ligand design & discovery; modeling and simulation of targets and ligand-target complexes of therapeutic interest; chemical biology
Contribution: Special Issue: Targeted Therapy
Dr. P. Hemachandra Reddy
Executive Director and Chief Scientific Officer of Garrison Institute on Aging, Professor of Cell Biology and Biochemistry, Neuroscience/Pharmacology and Neurology, Texas Tech University Health Sciences Center, 3601 4th Street / MS / 9424 / 4A 124, Lubbock, TX 79430, USA
Interests: aging; neurodegenerative diseases; gene expression analysis; transgenic mouse models; mitochondrial biology; mitochondrial function/dysfunction; mitochondrial therapeutics; mitochondrial dynamics
Contribution: Special Issue: Mitochondrial Drugs for Neurodegenerative Diseases
Special Issue: Genes, Mechanisms and Drugs for Asthma
Prof. Dr. Oliver Reiser
Institut für Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany
Interests: asymmetric catalysis; stereoselective synthesis; natural product; synthesis; unnatural amino acids; foldamers
Contribution: Special Issue: Asymmetric Synthesis and Medicinal Chemistry
Prof. Dr. Domenico Ribatti
Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso, Sezione di Anatomia Umana e Istologia, Piazza Giulio Cesare, 11 Policlinico, 70124 Bari, Italy
Interests: role of FGF-2 and VEGF in the vascularization of the chick embryo chorioallantoic membrane; angiogenesis
Contribution: Special Issue: Angiogenesis Inhibitors
Prof. Dr. Vladimir P. Torchilin
University Distinguished Professor, Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 140 The Fenway, room 214, 360 Huntington Avenue Boston, MA 02115, USA
Interests: drug carriers; drug delivery sytems; drug targeting; liposomes; micelles; experimental cancer immunology; imaging agents
Contribution: Special Issue: Cell-penetrating Peptides
In other journals:
Special Issue: Biodegradability of Materials
Special Issue: Biodegradability of Materials
Special Issue: Micellar Drug Delivery
Dr. Sonia Tucci
School of Psychology, University of Liverpool, Eleanor Rathbone Building, Bedford Street South, Liverpool, L37 2LE, UK
Interests: behavioural neuroscience; psychopharmacology; neurochemical correlates of behaviour; mechanisms of appetite regulation; brain cannabinoid function in relation to appetite and body weight regulation
Contribution: Special Issue: Phytochemicals with actions on the Central Nervous System
Dr. Guangshun Wang
Department of Pathology & Microbiology University of Nebraska Medical Center, USA
Interests: Host defense antimicrobial peptides, Structural bioinformatics, Biomolecular NMR
Contribution: Special Issue: Identification and Characterization of Antimicrobial Peptides with Therapeutic Potential
Special Issue: Antimicrobial Peptides: Expanded Activity Spectrum and Applications
Dr. Howard A. Young
Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/31-23, Chandler Street, Frederick, MD 21702-1201, USA
Interests: interferon-gamma; cytokines, interferons, post transcriptional mRNA regulation; interleukins
Contribution: Special Issue: Interferons
Special Issue: Interferons 2015
In other journals:
Special Issue: Cytokines in Cancer
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert